ESC Professional Premium Access

Advances in the treatment of inherited cardiac conditions: targeting the cause of disease

Event: ESC Congress 2022
Topic: Treatment
Session type: Symposium
Date: 28 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

RNA therapies: ready for prime time?

Speaker: Professor T. Thum (Hannover, DE)
Thumbnail

Gene editing in inherited cardiac disease: fact or fiction?

Speaker: Doctor M. Harakalova (Utrecht, NL)
Thumbnail

Small molecules in hypertrophic and dilated cardiomyopathies: is there enough evidence?

Speaker: Doctor C. Ho (Boston, US)
Thumbnail

Advances in the treatment of inherited cardiac conditions: targeting the cause of disease – discussion.

Thumbnail

3 speakers from this session

Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)
16 presentations
0 follower

Doctor Magdalena Harakalova

University Medical Center Utrecht, Utrecht (Netherlands (The))
1 presentation
0 follower

Doctor Carolyn Ho

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
2 presentations
1 follower

This platform is supported by

logo Novo Nordisk